Literature DB >> 11839851

Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD.

M Ulivelli1, S Rossi, C Lombardi, S Bartalini, R Rocchi, F Giannini, S Passero, N Battistini, E Lugaresi.   

Abstract

Both dopamine agonists and levodopa may induce episodes termed "sleep attacks" in patients with PD. These episodes are well detailed behaviorally, but little is known about their neurophysiologic characterization. The authors performed a 24-hour polysomnography (PSG) in a PD patient taking pergolide in combination with levodopa, in which four of these diurnal sleep episodes occurred. PSG findings were followed up after pergolide withdrawal. Sleep episodes shared with narcolepsy both behavioral and EEG findings. However, pergolide partly restored a more physiologic sleep architecture, which was disrupted during therapy with levodopa alone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839851     DOI: 10.1212/wnl.58.3.462

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study.

Authors:  A Romigi; P Stanzione; M G Marciani; F Izzi; F Placidi; A Cervellino; P Giacomini; L Brusa; K Grossi; M Pierantozzi
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

2.  Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers.

Authors:  E R Samuels; R H Hou; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2006-06-27       Impact factor: 4.530

3.  Sleepiness and Unintended Sleep in Parkinson's Disease.

Authors:  David B. Rye
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

Review 4.  Excessive daytime sleepiness in patients with Parkinson's disease.

Authors:  Bettina Knie; M Tanya Mitra; Kartik Logishetty; K Ray Chaudhuri
Journal:  CNS Drugs       Date:  2011-03       Impact factor: 5.749

Review 5.  Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 6.  'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?

Authors:  K Ray Chaudhuri; Suvankar Pal; Christine Brefel-Courbon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.

Authors:  Joëlle Micallef; Marc Rey; Alexandre Eusebio; Christine Audebert; Frank Rouby; Elisabeth Jouve; Sophie Tardieu; Oliver Blin
Journal:  Br J Clin Pharmacol       Date:  2008-09-19       Impact factor: 4.335

8.  Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients. An ambulatory polysomnographic study.

Authors:  Fabio Placidi; Francesca Izzi; Andrea Romigi; Paolo Stanzione; Maria Grazia Marciani; Livia Brusa; Francesca Sperli; Salvatore Galati; Patrizio Pasqualetti; Mariangela Pierantozzi
Journal:  J Neurol       Date:  2008-06-02       Impact factor: 4.849

Review 9.  Excessive daytime sleepiness and unintended sleep in Parkinson's disease.

Authors:  David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.